Cystic fibrosis may be a rare disease that only affect 30,000 Americans, Cramer concluded, but when the data say that your drug could successfully treat 46% of them, that news is a game changer.
No Huddle OffenseIn his "No Huddle Offense" segment, Cramer said it's time to learn how to love the short-sellers, those stock skeptics that the bulls love to hate. Cramer said that yes, short-sellers can be wrong or early with their doom-and-gloom predictions, but in today's trading, they could have saved investors a bundle.
Cramer said that the short-sellers predicted shortfalls at Fossil, MAKO Surgical (MAKO), Rackspace and Dendreon (DNDN) and all of these companies were hit especially hard as those predictions all came true in spectacular fashion.
Turns out that sometimes the skeptics can be right after all.
--Written by Scott Rutt in Washington, D.C.To contact the writer of this article, click here: Scott Rutt. Follow TheStreet on Twitter and become a fan on Facebook. To submit a news tip, send an email to: email@example.com. To watch replays of Cramer's video segments, visit the Mad Money page on CNBC. Click